Results 211 to 220 of about 11,899,379 (393)
Editorial: Methods in pediatric infectious diseases 2024. [PDF]
Kosmas I, Mota GA, Shi Z.
europepmc +1 more source
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.
H. Boucher +8 more
semanticscholar +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re-emergence. [PDF]
Batisani K, Joseph Ogunniyi T.
europepmc +1 more source
Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang +7 more
wiley +1 more source
Perspectives: Educating Transfusion Medicine Professionals in Planetary Health and Infectious Diseases: Should Blood Banks Have Dedicated Infectious Diseases Consultation Services? [PDF]
Miller MJ, De Giorgi V.
europepmc +1 more source
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang +8 more
wiley +1 more source
Editorial: Recent advancements in the research models of infectious diseases. [PDF]
Rajadas SE +4 more
europepmc +1 more source
Age‐Related Characteristics of SYT1‐Associated Neurodevelopmental Disorder
ABSTRACT Objectives We describe the clinical manifestations and developmental abilities of individuals with SYT1‐associated neurodevelopmental disorder (Baker‐Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations ...
Sam G. Norwitz +3 more
wiley +1 more source

